Europe Radiopharmaceuticals Market Size & Outlook

The radiopharmaceuticals market in Europe is expected to reach a projected revenue of US$ 8,866.9 million by 2030. A compound annual growth rate of 10.1% is expected of Europe radiopharmaceuticals market from 2025 to 2030.
Revenue, 2024 (US$M)
$4,586.7
Forecast, 2030 (US$M)
$8,866.9
CAGR, 2025 - 2030
10.1%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe radiopharmaceuticals market, 2018-2030 (US$M)

Europe radiopharmaceuticals market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe radiopharmaceuticals market highlights

  • The Europe radiopharmaceuticals market generated a revenue of USD 4,586.7 million in 2024.
  • The market is expected to grow at a CAGR of 10.1% from 2025 to 2030.
  • In terms of segment, diagnostics was the largest revenue generating product in 2024.
  • Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, France is expected to register the highest CAGR from 2025 to 2030.

Europe data book summary

Market revenue in 2024USD 4,586.7 million
Market revenue in 2030USD 8,866.9 million
Growth rate10.1% (CAGR from 2025 to 2030)
Largest segmentDiagnostics
Fastest growing segmentDiagnostics
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics, Therapeutics

Other key industry trends

  • In terms of revenue, Europe region accounted for 25.8% of the global radiopharmaceuticals market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 7,648.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiopharmaceuticals Market Companies

Name Profile # Employees HQ Website
Lantheus Medical Imaging, Inc. View profile - - -
GE Healthcare View profile 10001+ Chicago, Illinois, United States, North America http://www.gehealthcare.com
Positron Corp View profile 19 1777 Maryland Avenue, Niagara Falls, NY, United States, 14305 https://www.positron.com
Covidien View profile 10001+ Dublin, Dublin, Ireland, Europe http://www.covidien.com
Ntp Radioisotopes View profile 251-500 Brits, NA - South Africa, South Africa, Africa https://www.ntp.co.za/
Cardinal Health Inc View profile 48000 7000 Cardinal Place, Dublin, OH, United States, 43017 https://www.cardinalhealth.com

Europe radiopharmaceuticals market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiopharmaceuticals market will help companies and investors design strategic landscapes.


Diagnostics was the largest segment with a revenue share of 91.81% in 2024. Horizon Databook has segmented the Europe radiopharmaceuticals market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe Radiopharmaceuticals Product Outlook (Revenue, USD Million, 2018-2030)
    • Diagnostics
      • PET
        • F-18
        • SR-82/RB-82
        • Illuccix (gallium Ga 68 gozetotide)
        • Others
        • PYLARIFY (piflufolastat F 18)
      • SPECT
        • TC-99m
        • GA-67
        • Others
        • TL-201
        • I-123
    • Therapeutics
      • Beta Emitters
        • SM-153
        • I-131
        • Lu-177
        • Others
        • Y-90
        • Re-186
      • Alpha Emitters
        • Others
        • RA-223
      • Brachytherapy
        • Cesium-131
        • Iridium-192
        • Palladium-103
        • Iodine-125
        • Others
  • Europe Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2018-2030)
    • Oncology
    • Lymphoma
    • Urology
    • Neurology
    • Endocrine Tumor
    • Pulmonary Scans
    • Cardiology
      • SPECT
      • Therapeutic Applications
      • PET
    • Thyroid
      • SPECT
      • Therapeutic Applications
    • Other
    • Bone Metastasis
      • SPECT
      • Therapeutic Applications
  • Europe Radiopharmaceuticals End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • Others
    • Diagnostic Centers

Reasons to subscribe to Europe radiopharmaceuticals market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe radiopharmaceuticals market databook

  • Our clientele includes a mix of radiopharmaceuticals market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe radiopharmaceuticals market , including forecasts for subscribers. This continent databook contains high-level insights into Europe radiopharmaceuticals market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe radiopharmaceuticals market size, by country, 2018-2030 (US$M)

Europe Radiopharmaceuticals Market Outlook Share, 2024 & 2030 (US$M)

Europe radiopharmaceuticals market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online